Sec. 6. A multidisciplinary program of care must meet the following requirements:

(1) The health care system provides a prenatal social needs and behavioral health evaluation of each expectant mother, including verbal screening and toxicology testing for opioid use.

(2) Each expectant mother whose prenatal toxicology test is positive for opioids is eligible to receive prenatal, perinatal, and postnatal care described in this chapter.

(3) Each newborn child of an expectant mother described in subdivision (2) is eligible to receive neonatal care described in this chapter.

(4) The health care system recruits and trains physicians described in section 1(2) of this chapter to provide buprenorphine treatment for opioid use to expectant mothers and newborn children.

(5) The multidisciplinary program ensures provision of the services described in this chapter by the personnel described in section 1 of this chapter.

(6) Each expectant mother whose prenatal toxicology test is positive for opioids is referred within the health care system as follows:

(A) To a physician who:

(i) is described in section 1(2)(A) of this chapter;

(ii) has received training and federal drug enforcement agency certification in buprenorphine treatment of expectant mothers who are addicted to opioids; and

(iii) agrees to provide to the expectant mother the buprenorphine treatment.

(B) For behavioral health consultation and therapy:

(i) by a licensed social worker or therapist; and

(ii) within the physical location of the practice of the physician described in clause (A).

(C) For care coordination services provided within the physical location of the practice of the physician described in clause (A).

(D) For prenatal consultation with the delivery hospital's:

(i) special care nursery or neonatal intensive care unit; and

(ii) anesthesiology service to establish a plan of care for the expectant mother in labor and delivery while undergoing buprenorphine treatment.

(E) To a physician who:

(i) is described in section 1(2)(B) of this chapter;

(ii) has received training and federal drug enforcement agency certification in buprenorphine treatment of postpartum mothers described in this subdivision; and

(iii) agrees to provide to the postpartum mother the buprenorphine treatment.

(F) For any additional necessary behavioral health services for the expectant or postpartum mother, as described in section 1(1)(E) of this chapter.

(7) The health care system requires training for all perinatal and neonatal staff in the use of the modified Finnegan scoring tool to perform assessments of newborn children for neonatal abstinence syndrome.

(8) Each newborn child whose mother's prenatal toxicology test was positive for opioids is referred within the health care system as follows:

(A) To a physician who:

(i) is described in section 1(2)(B) of this chapter;

(ii) has received training and is proficient in the care and pharmacological treatment of neonatal abstinence syndrome; and

(iii) agrees to provide to the newborn the care and pharmacological treatment, as necessary.

(B) For behavioral health consultation and therapy:

(i) by a licensed social worker or therapist; and

(ii) within the physical location of the practice of the physician described in clause (A).

(C) For care and treatment in the delivery hospital's special care nursery or neonatal intensive care unit.

(D) For care coordination services provided within the physical location of the practice of the physician described in clause (A).

(E) If the newborn child is diagnosed with neonatal abstinence syndrome:

(i) for outpatient occupational, physical, and speech therapies; and

(ii) for outpatient developmental follow-up by a physician described in section 1(2)(B) of this chapter and by the infants and toddlers with disabilities program under IC 12-12.7-2.

(9) The health care system provides individuals who serve to cuddle newborn children described in subdivision (8).

(10) The health care system provides at least four (4) days of postpartum care in rooms equipped with hardwired monitoring, to observe for opioid withdrawal, to mothers described in subdivision (6) and their newborn children.

(11) The health care system provides for breastfeeding mothers described in subdivision (6) to stay in the hospital with their newborn child if the newborn child's hospital stay is extended due to treatment for neonatal abstinence syndrome.

(12) The health care system has personnel and resources (including project management, data collection, research coordination, and research evaluation personnel), and commits to perform data collection and analysis of the multidisciplinary program to do the following:

(A) Provide to the division, in a format specified by the division, annual data reflecting the health and economic outcomes of the program.

(B) Report best practices, barriers to treatment and recovery, and methods of removing identified barriers to treatment and recovery.

(C) Provide other information required by the division.

As added by P.L.168-2017, SEC.4.